seventy-six patients with advanced acute leukemia refractory to conventional chemotherapy were treated with a sequential combination of methotrexate ( mtx ) and l-asparaginase ( l-asp ) , based on the reported schedule-dependent synergism between the two drugs in human leukemic cells in vitro .
C0085669
acute leukemia
C1517806
leukemic cells